(1 - 27 von 38
)
BRIEF-Bruno Lucidi appointed permanent CEO of Karolinska Development...
www.reuters.com
* Bruno Lucidi appointed permanent ceo of karolinska development Source text for Eikon: Further company coverage:
Han blir ny vd för Karolinska Development
www.affarsvarlden.se
Karolinska Development får en ny vd i Bruno Lucidi, enligt ett pressmeddelande på onsdagen. Han tar över omedelbart.
globo: Pedro Bial estreia especial de fim de ano em que diz ser , resultado...
... a cantora Elza Soares, septuagenária que mostra seu vigor na linha "força da natureza" e apresenta o marido, Bruno Lucidi, na casa dos 20.
Karolinska Development AB: CEO Bruno Lucidi leaves Karolinska...
www.finanznachrichten.de
Stockholm - January 28, Karolinska Development AB today announced that the company's CEO Bruno Lucidi leaves the company. He is replaced by Deputy CEO...
BRIEF-Karolinska Development CEO Bruno Lucidi leaves, replaced by...
www.reuters.com
* Lucidi is replaced by deputy CEO Terje Kalland until a new, permanent CEO is appointed.
Karolinska Development AB: Karolinska Development's Extraordinary...
www.finanznachrichten.de
STOCKHOLM - December 4, At the Extraordinary General Meeting of Karolinska Development AB held today, the following resolutions were passed, in...
Bruno Lucidi new CEO in Karolinska Development oncology
www.globenewswire.com
Bruno Lucidi has extensive international experience in the … industry. In his previous positions as CEO of Idenix and Chairman of Pharmasset,...
Bruno Lucidi appointed permanent CEO of Karolinska
www.globenewswire.com
“We are happy to welcome Bruno Lucidi as permanent CEO”, says Karolinska Development’s Chairman Bo Jesper Hansen. “As communicated on September 30, 2014,...
Karolinska Development : Bruno Lucidi appointed permanent CEO of...
www.marketscreener.com
Bruno Lucidi appointed permanent CEO of Karolinska Development STOCKHOLM - October 15, Karolinska Development today announces that Bruno...
Aprea Granted European Orphan Drug Designation for APR-246 in Ovarian...
www.technologynetworks.com
Company is currently conducting a Phase Ib/II trial of APR-246.
Athera Initiates Phase I Trial with its Fully Human Antibody PC-mAb |...
www.technologynetworks.com
Current Phase I study is performed in Uppsala by CTC Clinical Trial Consultants AB.
Forendo Licenses U.S. Fispemifene Rights to Apricus for Up-to-$305Mwww.genengnews.com › news
www.genengnews.com
· ... with hypogonadism and other male urological conditions,” added Bruno Lucidi, CEO, Karolinska Development, which owns 21% of Forendo.
Clanotech receives orphan drug designation in the EU - dgap.de
www.eqs-news.com
Clanotech receives orphan drug designation in the EU | Karolinska Development AB | News | Nachricht | Mitteilung
Banconista di pizzeria
www.corrierenews.it
Attività commerciale di Fermo ricerca 1 banconista di pizzeria. Si offre contratto di apprendistato, part-time 30 ore settimanali. Codice offerta:
Medical Technology Business Europe business news
www.mtbeurope.info
Swedish medical technology company Karolinska Development has announced that Bruno Lucidi has been appointed as permanent CEO from today, ...
Event healthtech invest europe 2017
www.iventureclub.com
Bruno Lucidi (AWEX - Foreign Trade and Investment Agency). Jari Mieskonen (Conor Venture Partners Oy). Kim Neel Wyon (Optiteam).
Healthtech Invest Europe Tech Tourtechtour.com › events › event-heal...
techtour.com
Bruno Lucidi (AWEX - Foreign Trade and Investment Agency). Jari Mieskonen (Conor Venture Partners Oy). Kim Neel Wyon (Optiteam).
Tech Tour
www.e-unlimited.com
Bruno Lucidi (AWEX - Foreign Trade and Investment Agency). Jari Mieskonen (Conor Venture Partners Oy). Kim Neel Wyon (Optiteam).
Karolinska Development secures life sciences funding from CP Group
www.mtbeurope.info
Bruno Lucidi, CEO of Karolinska Development AB, added, “We recently announced a number of distinct changes in Karolinska Development's ...
Karolinska Development appoints new CEO
www.mtbeurope.info
Swedish medical technology company Karolinska Development has announced that Bruno Lucidi has been appointed as permanent CEO from ...
OssDsign's bioceramic Cranioplug gains FDA approval
www.mtbeurope.info
... regulatory knowledge can achieve significant value creation within a very short timeframe”, said Bruno Lucidi, CEO, Karolinska Development.
Forendo Pharma Announces the US Licensing of Fispemifene ...www.technologynetworks.com › news › forendo-ph...
www.technologynetworks.com
· ... for the millions of men affected with hypogonadism and other male urological conditions” said Bruno Lucidi, CEO, Karolinska Development.
Let's Play, con i ragazzi che creano videogiochi: 'Per favore...
www.ilfattoquotidiano.it
Bruno Lucidi e Francesco Furfari invece si sono diplomati quest'estate e già a scuola sapevano che avrebbero fatto videogiochi. E poi c'è lei, Giada Moriconi, 28 anni. Quando la incontro sta realizzando un troll in 3d sul computer. “E' scultura digitale – racconta in una lingua a me comprensibile – si usano ...
Karolinska Development AB (publ) – Interim Report January –...
view.news.eu.nasdaq.com
Bruno Lucidi, CEO, comments: “My appointment as CEO of Karolinska Development coincides with the announcement of a new strategy for the ...
OssDsign’s Cranioplug receives marketing approval in the US - dgap.de
www.eqs-news.com
OssDsign’s Cranioplug receives marketing approval in the US | Karolinska Development AB | News | Nachricht | Mitteilung
Surprise departure of Karolinska Development chief executive ...sciencebusiness.net › news › Surprise-departure-of-...
sciencebusiness.net
· Swedish life sciences investor Karolinska Development AB and its chief executive officer, Bruno Lucidi, have parted ways after only three ...
sortiert nach Relevanz / Datum